Infertility Following Pelvic Inflammatory Disease
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Dysmenorrhoea
[ Color index: Important | Notes| Extra | Video Case ] Editing file link Dysmenorrhoea Objectives: ➢ Define dysmenorrhea and distinguish primary from secondary dysmenorrhea ➢ • Describe the pathophysiology and identify the etiology ➢ • Discuss the steps in the evaluation and management options References : Hacker and moore, Kaplan 2018, 428 boklet ,433 , video case Done by: Omar Alqahtani Revised by: Khaled Al Jedia DYSMENORRHEA Definition: dysmenorrhea is a painful menstruation it could be primary or secondary Primary dysmenorrhea Definition: Primary dysmenorrhea refers to recurrent, crampy lower abdominal pain, along with nausea, vomiting, and diarrhea, that occurs during menstruation in the absence of pelvic pathology. It is the most common gynecologic complaint among adolescent girls. Characteristic: The onset of pain generally does not occur until ovulatory menstrual cycles are established. Maturation of the hypothalamic-pituitary-gonadal axis leading to ovulation occurs in half of the teenagers within 2 years post-menarche, and the majority of the remainder by 5 years post-menarche. (so mostly it’s occur 2-5 years after first menstrual period) • The symptoms typically begin several hours prior to the onset of menstruation and continue for 1 to 3 days. • The severity of the disorder can be categorized by a grading system based on the degree of menstrual pain, the presence of systemic symptoms, and impact on daily activities Pathophysiology Symptoms appear to be caused by excess production of endometrial prostaglandin F2α resulting from the spiral arteriolar constriction and necrosis that follow progesterone withdrawal as the corpus luteum involutes. The prostaglandins cause dysrhythmic uterine contractions, hypercontractility, and increased uterine muscle tone, leading to uterine ischemia. -
Risk of First Trimester Spontaneous Miscarriage Among Singleton
Middle East Fertility Society Journal (2013) xxx, xxx–xxx Middle East Fertility Society Middle East Fertility Society Journal www.mefsjournal.org www.sciencedirect.com ORIGINAL ARTICLE Risk of first trimester spontaneous miscarriage among singleton gestations following ICSI and its relation to underlying cause of infertility Wessam Magdi Abuelghar a,*, Osama Saleh Elkady a, Tarek Fathi. Tamara a, Mona Hassan Khalil b a Obstetrics and Gynaecology Department, Ain-shams University, Cairo, Egypt b Obstetrics and Gynaecology Department, El Khazendara MOH Hospital, Cairo, Egypt Received 16 April 2013; accepted 12 June 2013 KEYWORDS Abstract Study objective: To assess the association between the first trimester miscarriage rates Miscarriage; among women undergoing intracytoplasmic sperm injection (ICSI) and underlying etiology of ICSI; infertility. Infertility Design: Prospective cohort study. Setting: Ain Shams University maternity hospital. Materials and methods: The study included women who became pregnant with singleton preg- nancy following ICSI as a treatment for different causes of infertility. Women were followed up throughout the first trimester of pregnancy up to 12 weeks’ gestation (10 weeks after the day of embryo transfer). Main outcome measure: First trimester miscarriage rate. Results: Two hundred and thirty four pregnant young women were included in the study, 164 (70.9%) women miscarried. The causes of infertility among these women were as follows: 41 (25%) mild male factor infertility, 40 (24.4%) severe male factor infertility, 45 (27.44%) tubal fac- tor, 7 (4.27%) polycystic ovarian syndrome, 3 (1.83%) endometriosis, 20 (12.19%) unexplained and Abbreviations: BMI, body mass index; CI, confidence interval; E2, estradiol; ET, embryo transfer; FSH, follicle stimulating hormone; GnRH, gonadotropin-releasing hormone; hCG, human chorionic gonadotropin; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; LH, luteinizing hormone; LMP, last menstrual period; OR, odds ratio; SD, standard deviation * Corresponding author. -
The Woman with Postmenopausal Bleeding
THEME Gynaecological malignancies The woman with postmenopausal bleeding Alison H Brand MD, FRCS(C), FRANZCOG, CGO, BACKGROUND is a certified gynaecological Postmenopausal bleeding is a common complaint from women seen in general practice. oncologist, Westmead Hospital, New South Wales. OBJECTIVE [email protected]. This article outlines a general approach to such patients and discusses the diagnostic possibilities and their edu.au management. DISCUSSION The most common cause of postmenopausal bleeding is atrophic vaginitis or endometritis. However, as 10% of women with postmenopausal bleeding will be found to have endometrial cancer, all patients must be properly assessed to rule out the diagnosis of malignancy. Most women with endometrial cancer will be diagnosed with early stage disease when the prognosis is excellent as postmenopausal bleeding is an early warning sign that leads women to seek medical advice. Postmenopausal bleeding (PMB) is defined as bleeding • cancer of the uterus, cervix, or vagina (Table 1). that occurs after 1 year of amenorrhea in a woman Endometrial or vaginal atrophy is the most common cause who is not receiving hormone therapy (HT). Women of PMB but more sinister causes of the bleeding such on continuous progesterone and oestrogen hormone as carcinoma must first be ruled out. Patients at risk for therapy can expect to have irregular vaginal bleeding, endometrial cancer are those who are obese, diabetic and/ especially for the first 6 months. This bleeding should or hypertensive, nulliparous, on exogenous oestrogens cease after 1 year. Women on oestrogen and cyclical (including tamoxifen) or those who experience late progesterone should have a regular withdrawal bleeding menopause1 (Table 2). -
Vaginitis and Cervicitis in the Clinic 2009.Pdf
in the clinic Vaginitis and Cervicitis Prevention page ITC3-2 Screening page ITC3-3 Diagnosis page ITC3-5 Treatment page ITC3-10 Practice Improvement page ITC3-14 CME Questions page ITC3-16 Section Co-Editors: The content of In the Clinic is drawn from the clinical information and Christine Laine, MD, MPH education resources of the American College of Physicians (ACP), including Sankey Williams, MD PIER (Physicians’ Information and Education Resource) and MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine Science Writer: editors develop In the Clinic from these primary sources in collaboration with Jennifer F. Wilson the ACP’s Medical Education and Publishing Division and with the assistance of science writers and physician writers. Editorial consultants from PIER and MKSAP provide expert review of the content. Readers who are interested in these primary resources for more detail can consult http://pier.acponline.org and other resources referenced in each issue of In the Clinic. CME Objective: To gain knowledge about the management of patients with vagini- tis and cervicitis. The information contained herein should never be used as a substitute for clinical judgment. © 2009 American College of Physicians in the clinic he vagina has a squamous epithelium and is susceptible to bacterial vaginosis, trichomoniasis, and candidiasis. Vaginitis may also result Tfrom irritants, allergic reactions, or postmenopausal atrophy. The endocervix has a columnar epithelium and is susceptible to infection with Neisseria gonorrhoeae, Chlamydia trachomatis, or less commonly, herpes sim- plex virus. Vaginitis causes discomfort, but rarely has serious consequences except during pregnancy and gynecologic surgery. Cervicitis may be asymptomatic and if untreated, can lead to pelvic inflammatory disease (PID), which can damage the reproductive organs and lead to infertility, ectopic pregnancy, or chronic pelvic pain. -
Anti-Chalmydial Antibody As a Predictive Test for Tubal Factor Infertility
Al-Azhar Med. J. Vol. 49(1), January, 2020, 229-240 DOI : 10.12816/amj.2020.67131 https://amj.journals.ekb.eg/article_67131.html ANTI-CHALMYDIAL ANTIBODY AS A PREDICTIVE TEST FOR TUBAL FACTOR INFERTILITY By Emad A. El-Tamamy, Ashraf H. Mohamed, Wael R. Hablas* and Shaban H. Abd El-Rahman ** Departments of Obstetrics & Gynecology and Clinical Pathology*, Faculty of Medicine, Al-Azhar University **Corresponding E-mail: [email protected] ABSTRACT Background: Infertility is a common gynaecological problem that has a multi factorial aetiology. Conception and pregnancy depend on complex physiological, anatomic and immunological factors. Objective: to evaluate the prevalence of chlamydial infection, especially subclinical cases, in a population of Egyptian tubal infertile women and to relate it to history, symptoms, clinical, and laparoscopy findings. Finally, to find any advantage of detecting antichlamydial antibodies in serum of these patients and evaluate its importance in prediction of tubal factor of infertility. Patients and Methods: This study includes 50 primary or secondary infertile females (patients group) their age between 20-30 years, and 50 random fertile females (control group) and Blood sample for IgG, Chlamydia trachomatis antibodies were drawn from all cases of the study for ELISA test. Results: The prevalence rate of Chlamydia trachomatis IgG antibodies was significantly higher in infertile group than that of control group. There was significant higher rate and ratio of positive results in infertile group than that of control group concerning anti-chlamydial IgG. There was a strong correlation between serum levels of anti-chlamydial IgG in the infertility patients. There was a significant correlation between serum anti-chlamydial IgG levels and the duration of infertility. -
Invasive Non-Typeable Haemophilus Influenzae Infection Due To
Nishimura et al. BMC Infectious Diseases (2020) 20:521 https://doi.org/10.1186/s12879-020-05193-2 CASE REPORT Open Access Invasive non-typeable Haemophilus influenzae infection due to endometritis associated with adenomyosis Yoshito Nishimura1* , Hideharu Hagiya1, Kaoru Kawano1, Yuya Yokota1, Kosuke Oka1, Koji Iio2, Kou Hasegawa1, Mikako Obika1, Tomoko Haruma3, Sawako Ono4, Hisashi Masuyama3 and Fumio Otsuka1 Abstract Background: The widespread administration of the Haemophilus influenzae type b vaccine has led to the predominance of non-typable H. influenzae (NTHi). However, the occurrence of invasive NTHi infection based on gynecologic diseases is still rare. Case presentation: A 51-year-old Japanese woman with a history of adenomyoma presented with fever. Blood cultures and a vaginal discharge culture were positive with NTHi. With the high uptake in the uterus with 67Ga scintigraphy, she was diagnosed with invasive NTHi infection. In addition to antibiotic administrations, a total hysterectomy was performed. The pathological analysis found microabscess formations in adenomyosis. Conclusions: Although NTHi bacteremia consequent to a microabscess in adenomyosis is rare, this case emphasizes the need to consider the uterus as a potential source of infection in patients with underlying gynecological diseases, including an invasive NTHi infection with no known primary focus. Keywords: Non-typable Haemophilus influenzae,Bacteremia,β-Lactamase-nonproducing ampicillin-resistance, Adenomyosis, Case report Background In Japan, a recent nationwide population-based sur- Haemophilus influenzae, a gram-negative coccobacillus, veillance study revealed that NTHi and H. influenzae is a common cause of respiratory tract infections (e.g., type f became the predominant isolates associated with pneumonia) and meningitis, particularly in children [1–3]. -
Detection of Mycoplasma Genitalium in Women with Laparoscopically
463 MYCOPLASMA GENITALIUM Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis C R Cohen, N R Mugo, S G Astete, R Odondo, L E Manhart, J A Kiehlbauch, W E Stamm, P G Waiyaki, P A Totten ............................................................................................................................... Sex Transm Infect 2005;81:463–466. doi: 10.1136/sti.2005.015701 Objectives: Mycoplasma genitalium has been associated with cervicitis, endometritis, and tubal factor See end of article for infertility. Because the ability of this bacterium to ascend and infect the fallopian tube remains undefined, authors’ affiliations we performed an investigation to determine the prevalence of M genitalium in fallopian tube, endometrial, ....................... and cervical specimens from women laparoscopically diagnosed with acute salpingitis in Nairobi, Kenya. Correspondence to: Methods: Women presenting with pelvic inflammatory disease were laparoscopically diagnosed with Craig R Cohen, MD, MPH, salpingitis. Infection with M genitalium in genital specimens was determined by polymerase chain reaction 74 New Montgomery Street, Suite 600, UCSF, (PCR). Box 0886, San Francisco, Results: Of 123 subjects with acute salpingitis, M genitalium was detected by PCR in the cervix and/or CA 94105, USA; ccohen@ endometrium in nine (7%) participants, and in a single fallopian tube specimen. In addition, those infected psg.ucsf.edu with M genitalium were more often HIV infected than women not infected by M genitalium (seven of nine Accepted for publication (78%) v 42 of 114 (37%), p,0.03). 26 April 2005 Conclusions: M genitalium is able to ascend into the fallopian tube, but its association with tubal pathology ....................... requires further investigation. elvic inflammatory disease (PID) is the most common the female upper genital tract and cause tubal disease has not serious gynaecological disorder diagnosed in women and been firmly established. -
Tubal Damage, Infertility and Tubal Ectopic Pregnancy: Chlamydia Trachomatis and Other Microbial Aetiologies
2 Tubal Damage, Infertility and Tubal Ectopic Pregnancy: Chlamydia trachomatis and Other Microbial Aetiologies Louise M. Hafner and Elise S. Pelzer Institute of Health and Biomedical Innovation, (IHBI), Queensland University of Technology (QUT) Australia 1. Introduction Infertility is a worldwide health problem with one in six couples suffering from this condition and with a major economic burden on the global healthcare industry. Estimates of the current global infertility rate suggest that 15% of couples are infertile (Zegers- Hochschild et al., 2009) defined as: (1) failure to conceive after one year of unprotected sexual intercourse (i.e. infertility); (2) continual failure of implantation at subsequent cycles of assisted reproductive technology; or (3) persistent miscarriage events without difficulty conceiving (natural conceptions). Tubal factor infertility is among the leading causes of female factor infertility accounting for 7-9.8% of all female factor infertilities. Tubal disease directly causes from 36% to 85% of all cases of female factor infertility in developed and developing nations respectively and is associated with polymicrobial aetiologies. One of the leading global causes of tubal factor infertility is thought to be symptomatic (and asymptomatic in up to 70% cases) infection of the female reproductive tract with the sexually transmitted pathogen, Chlamydia trachomatis. Infection-related damage to the Fallopian tubes caused by Chlamydia accounts for more than 70% of cases of infertility in women from developing nations such as sub-Saharan Africa (Sharma et al., 2009). Bacterial vaginosis, a condition associated with increased transmission of sexually transmitted infections including those caused by Neisseria gonorrhoeae and Mycoplasma genitalium is present in two thirds of women with pelvic inflammatory disease (PID). -
Population Attributable Fraction of Tubal Factor Infertility Associated with Chlamydia
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Am J Obstet Manuscript Author Gynecol. Author Manuscript Author manuscript; available in PMC 2018 September 01. Published in final edited form as: Am J Obstet Gynecol. 2017 September ; 217(3): 336.e1–336.e16. doi:10.1016/j.ajog.2017.05.026. Population Attributable Fraction of Tubal Factor Infertility Associated with Chlamydia Rachel J. GORWITZ, MD, MPH1, Harold C. WIESENFELD, MD, CM2,3, Pai Lien CHEN, PhD4, Ms. Karen R. HAMMOND, DNP, CRNP5, Ms. Karen A. SEREDAY, MS1, Catherine L. HAGGERTY, PhD, MPH3,6, Robert E. JOHNSON, MD, MPH1, John R. PAPP, PhD1, Dmitry M. KISSIN, MD, MPH1, Tara C. HENNING, PhD1, Edward W. HOOK III, MD7, Michael P. STEINKAMPF, MD, MA5, Lauri E. MARKOWITZ, MD1, and William M. GEISLER, MD, MPH7 1Centers for Disease Control and Prevention, Atlanta, GA 2Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 3Magee-Womens Research Institute, Pittsburgh, PA 4FHI360, Durham, NC 5Alabama Fertility Specialists, Birmingham, AL 6Department of Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA 7Department of Medicine, University of Alabama at Birmingham, Birmingham, AL Abstract Background—Chlamydia trachomatis infection is highly prevalent among young women in the United States. Prevention of long-term sequelae of infection, including tubal factor infertility, is a primary goal of chlamydia screening and treatment activities. However, the population attributable fraction of tubal factor infertility associated with chlamydia is unclear, and optimal measures for assessing tubal factor infertility and prior chlamydia in epidemiologic studies have not been established. Black women have increased rates of chlamydia and tubal factor infertility compared Corresponding author: Rachel J. -
Increased Prevalence of Endocervical Mycoplasma and Ureaplasma Colonization in Infertile Women with Tubal Factor
JBRA Assisted Reproduction 2020;24(2):152-157 doi: 10.5935/1518-0557.20190078 Original article Increased prevalence of endocervical Mycoplasma and Ureaplasma colonization in infertile women with tubal factor Rita CCP Piscopo1, Ronney V Guimarães1, Joji Ueno1,2, Fabio Ikeda1,2, Zsuzsanna IK Jarmy-Di Bella3, Manoel JBC Girão3, Marise Samama1,3 1Clinical Department, Instituto Gera de Medicina Reprodutiva, São Paulo, SP, Brazil 2Video-Hysteroscopy Section, Hospital Sírio Libanês, São Paulo, SP, Brazil 3Gynecology Department, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, SP, Brazil This study was presented as a poster at the ESHRE Annual Meeting 2018, held in Barcelona – Spain on July 01-04, 2018 ABSTRACT damage seems to be the foremost way in which infections Objective: Most women suffering from tubal factor in- affect women’s fertility. Pathogenic microorganisms colo- fertility do not have a history of pelvic inflammatory dis- nizing the lower female genital tract may ascend to the ease, but rather have asymptomatic upper genital tract in- upper genital tract, causing pelvic inflammatory disease fection. Investigating the impacts of such infections, even (PID) associated with tubal damage, and ultimately to in- in the absence of clinically confirmed pelvic inflammatory fertility. In the presence of infection, tubal damage may disease, is critical to understanding the tubal factor of in- occur in response to adhesions, damage to the tubal mu- fertility. The aim of this study was to investigate whether cosa or tubal occlusion impairing oocyte transport (Rho- the presence of endocervical bacteria is associated with ton-Vlasak, 2000). tubal factors in women screened for infertility. -
Tubo-Ovarian Abscess in OPAT
Tubo-ovarian abscess in OPAT James Hatcher Consultant in Infectious Diseases and Medical Microbiology OUTLINE • What is a tubo-ovarian abscess • Current recommendations • Our experience and challenges • How to improve service Images from CDC Public Health Image Library Pelvic inflammatory disease • Pelvic inflammatory disease is the overall term for infection ascending from the endocervix • Neisseria gonorrhoeae and Chlamydia trachomatis have been identified as causative agents • IUD increases risk of PID but only for 4-6 weeks post insertion • Symptoms – Lower abdo pain, discharge, dyspareunia, abnormal vaginal bleeding • Signs – Bilateral lower abdo tenderness, fever – Adnexal tenderness on bimanual vaginal examination Peritonitis Sepsis Salpingitis Endometritis Oophoritis Tubo-ovarian abscess Cervicitis 2018 United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease ‘Admission for parenteral therapy, observation, further investigation and/or possible surgical intervention should be considered in the following situations (Grade 1D) • Lack of response to oral therapy • Clinically severe disease • Presence of a tubo-ovarian abscess • Intolerance to oral therapy’ Inpatient regimens IV ceftriaxone 2g OD PLUS doxycycline 100mg BD PLUS metronidazole 400mg BD for 14 days (Grade 1A) IV therapy should be continued until 24 hours after clinical improvement then switched to oral (Grade 2D) Surgical management Laparoscopy may help severe disease by dividing adhesions and draining abscesses Ultrasound guided aspiration is -
Infertility: an Overview
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Infertility: An Overview A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications Committee. No portion herein may be reproduced in any form without written permission. This booklet is in no way intended to replace, dictate, or fully define evaluation and treatment by a qualified physician. It is intended solely as an aid for patients seeking general information on issues in reproductive medicine. Copyright © 2017 by the American Society for Reproductive Medicine AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Infertility: An Overview A Guide for Patients, Revised 2017 A glossary of italicized words is located at the end of this booklet. INTRODUCTION Infertility is typically defined as the inability to achieve pregnancy after one year of unprotected intercourse. If you have been trying to conceive for a year or more, you should consider an infertility evaluation. However, if you are 35 years or older, you should consider beginning the infertility evaluation after about six months of unprotected intercourse rather than a year, so as not to delay potentially needed treatment. If you have a reason to suspect an underlying problem, you should seek care earlier. For instance, if you have very irregular menstrual cycles (suggesting that you are not ovulating or releasing an egg), or if you or your partner has a known fertility problem, you probably should not wait an entire year before seeking treatment. If you and your partner have been unable to have a baby, you’re not alone.